INTRA-TRAC
® 3
Intervet/Schering-Plough Animal Health
Canine Adenovirus Type 2-Parainfluenza-Bordetella Bronchiseptica Vaccine
Modified Live Virus, Avirulent Live Culture
DIRECTIONS FOR USE - PLEASE READ CAREFULLY
Intra-Trac® 3 vaccine is recommended for use as an aid in the prevention of disease associated with canine adenovirus type 2, canine parainfluenza virus and Bordetella bronchiseptica infection in healthy dogs 3 weeks of age or older. These agents have been implicated as playing a role in the etiology of the condition known as canine kennel cough.
WHEN TO VACCINATE
Vaccinate dogs at 3 weeks of age or older. Annual revaccination is recommended.
PREPARATION OF THE VACCINE
1. Rehydrate live vaccine to desired volume with the accompanying Sterile Diluent.*
2. Draw the vaccine back into syringe.
3. Remove needle from syringe.
4. Apply nasal applicator tip to syringe.
HOW TO VACCINATE
1 Dose - *Standard dose is 1 mL administered intranasally. Vaccine may be rehydrated with less than 1 mL of diluent to minimize discomfort when vaccinating small dogs and puppies. For one 1 mL dose, rehydrate vaccine with 1 mL sterile diluent or for one 0.5 mL dose, rehydrate vaccine with 0.5 mL sterile diluent. Instill the rehydrated vaccine into one or both nostrils of dogs as illustrated below.
5 Dose - *Standard dose is 1 mL administered intranasally. Vaccine may be rehydrated with less than 5 mL of diluent to minimize discomfort when vaccinating small dogs and puppies. For five 1 mL doses, rehydrate vaccine with 5 mL sterile diluent or for five 0.5 mL doses, rehydrate vaccine with 2.5 mL sterile diluent. Instill the rehydrated vaccine into one or both nostrils of five dogs as illustrated below.
CAUTION
1. THIS PRODUCT IS DESIGNED FOR INTRANASAL USE ONLY WITH THE ENCLOSED APPLICATORS. Systemic reactions resulting from inadvertent intramuscular or subcutaneous injection have been reported. Symptoms may include vomiting, diarrhea, lethargy, inappetence, jaundice and death associated with liver failure. Localized tissue necrosis at the injection site has also been reported. If inadvertent injection occurs, monitor the dog closely. Supportive therapy including IV fluids and treatment with gentamicin, tetracycline, trimethoprim/sulfa or amoxicillin/clavulanic acid may be indicated. If anaphylactoid reaction occurs, use epinephrine.
2. Post-vaccinal reactions consisting of mild canine cough syndrome may occur following use of this vaccine.
3. For veterinary use only. Store at 2° - 7°C (35° - 45°F). Use entire contents when first opened. Burn all containers, nasal applicators, vaccine vials and all unused contents.
4. This vaccine contains penicillin, streptomycin and nystatin as preservatives.
NOT FOR PARENTERAL USE
For veterinary use in dogs only.
U.S. Veterinary License No. 165A
Schering-Plough Animal Health Corp., Omaha, Nebraska 68103, USA
1 800 224-5318 (USA)
© Copyright 2000, 2002, 2004, 2006 Schering-Plough Animal Health Corp.
All rights reserved.
|
|
NDC
|
|
|
25x1 DOSE - VARIED DOSE VOLUME
|
0061-1391-01
|
P13946-13, P13944-13
|
|
2x5 Dose - VARIED DOSE VOLUME
|
0061-1391-03
|
P13953-11, P13945-11
|
NAC No.: 10472402